4.4 Review

Dapsone in Hidradenitis Suppurativa: A Systematic Review

期刊

DERMATOLOGY AND THERAPY
卷 12, 期 2, 页码 285-293

出版社

ADIS INT LTD
DOI: 10.1007/s13555-021-00674-x

关键词

Hidradenitis suppurativa; Acne inversa; Dapsone

向作者/读者索取更多资源

Hidradenitis suppurativa is a chronic, inflammatory, recurrent disease with limited evidence supporting the efficacy of dapsone as a treatment. More well-designed randomized controlled trials are needed to support its usage.
Introduction Hidradenitis suppurativa (HS) is a chronic, inflammatory, recurrent disease, usually presenting after puberty with inflammatory lesions that mainly affect the apocrine gland-bearing areas of the body, most commonly the axillary, inguinal and anogenital regions. The treatment of HS is associated with certain challenges due to intrinsic resistance to various treatments and the presence of comorbidities and complications. The antibiotic dapsone is an established treatment for HS, but the current evidence base is limited. The aim of this review is to systematically review the literature on the efficacy of dapsone in the treatment of HS. Methods The Cochrane, PubMed and CINAHL databases were searched for relevant articles to be included in the systematic review. Results A total of seven studies, with a cumulative patient population of 135 patients, were included. Of these 135 patients, 62.2% demonstrated various degrees of improvement following treatment. However, as only three of the seven studies used dapsone monotherapy it is difficult to assess the effectiveness of dapsone because the benefits observed may be due to concurrently administered treatment. Conclusion Overall, the quality of evidence supporting the use of dapsone is weak. However, it is a well established treatment recommended in current, various national guidelines. There is a crucial need for well-designed randomized controlled trials to support its usage.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据